Literature DB >> 6305632

Receptor-mediated mitogenic action of prolactin in a rat lymphoma cell line.

R P Shiu, H P Elsholtz, T Tanaka, H G Friesen, P W Gout, C T Beer, R L Noble.   

Abstract

PRL and other lactogenic hormones are potent mitogens in a lymphoma cell line derived from a lymph node of an estrogenized Noble (Nb) rat. The present study demonstrates that these cells (designated Nb2 node) possess receptors that bind only lactogenic hormones. There are approximately 12,000 receptor sites per cell. The kinetics of binding of [125I]iodo-PRL exhibited by Nb2 lymphoma cells is unusual in that PRL binding follows a biphasic pattern. Binding of [125I]iodo-PRL reaches a maximum in 1 h at 37 C, followed by a rapid decline. This pattern was not observed if binding was carried out in the presence of chloroquine, a lysosomotropic agent, or if cell homogenate was used for binding. We also examined the relationship between receptor occupancy and the magnitude of PRL response in these cells. Maximal growth stimulation by PRL occurs when only 35% of the maximal binding of PRL is achieved, suggesting that a majority of the PRL binding sites may be spare receptors. This study also revealed that the dissociation constant (Kd) of the PRL receptors in Nb2 cells is 75 pM, approximately 20-fold higher than that of the receptors in other cell types. PRL at 6 pM produces a half-maximal growth response in the Nb2 cells. Antibodies against the PRL receptors are able to abolish the PRL-induced proliferation of Nb2 cells. In the absence of PRL, these antibodies alone can induce proliferation of Nb2 cells, mimicking the action of PRL. Divalent (Fab)2 fragments, but not monovalent Fab, were also effective. These observations suggest that antibodies to the receptor, or the hormone itself, initiate a biological response possibly by cross-linking PRL receptors on the cell membrane, and that the entry of the PRL molecule, or fragments of it, into the intracellular compartment is not necessary for the biological action of PRL.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6305632     DOI: 10.1210/endo-113-1-159

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

1.  The forgotten lactogenic activity of growth hormone: important implications for rodent studies.

Authors:  Andrzej Bartke; John J Kopchick
Journal:  Endocrinology       Date:  2015-03-02       Impact factor: 4.736

Review 2.  The role of prolactin in the pathogenesis of autoimmune disease.

Authors:  Istvan Berczi
Journal:  Endocr Pathol       Date:  1993-12       Impact factor: 3.943

3.  A comparison of lactogenic receptors from rat liver and Nb2 rat lymphoma cells by using cross-linking techniques.

Authors:  C F Webb; M Wallis
Journal:  Biochem J       Date:  1988-02-15       Impact factor: 3.857

4.  New homologous bioassays for human lactogens show that agonism or antagonism of various analogs is a function of assay sensitivity.

Authors:  Sophie Bernichtein; Sébastien Jeay; Roland Vaudry; Paul A Kelly; Vincent Goffin
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

5.  Inhibition of Nb2 T-lymphoma cell growth by transforming growth factor-beta.

Authors:  E J Rayhel; D A Prentice; P S Tabor; W H Flurkey; R W Geib; R F Laherty; S B Schnitzer; R Chen; J P Hughes
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

6.  Anterior pituitary hormone control by interleukin 2.

Authors:  S Karanth; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

7.  50 kD prolactin binding protein in schizophrenics on neuroleptic medication.

Authors:  A M Walker; C A Peabody; T W Ho; M D Warner
Journal:  J Psychiatry Neurosci       Date:  1992-06       Impact factor: 6.186

8.  Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice.

Authors:  Teresa A Rose-Hellekant; Lisa M Arendt; Matthew D Schroeder; Kennedy Gilchrist; Eric P Sandgren; Linda A Schuler
Journal:  Oncogene       Date:  2003-07-24       Impact factor: 9.867

9.  Identification and functional activity of prolactin receptors in thymic epithelial cells.

Authors:  M Dardenne; P A Kelly; J F Bach; W Savino
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

10.  Prolactin-immunoglobulin G complexes from human serum act as costimulatory ligands causing proliferation of malignant B lymphocytes.

Authors:  A M Walker; D W Montgomery; S Saraiya; T W Ho; H S Garewal; J Wilson; L Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.